Company Filing History:
Years Active: 1989
Title: The Innovations of Charles W. Todd
Introduction
Charles W. Todd is a notable inventor based in Arcadia, CA (US). He has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. His work has implications for the detection of important cancer markers, showcasing the intersection of innovation and healthcare.
Latest Patents
Todd holds a patent for a specific hybridoma cell line and the monoclonal antibodies produced from it. This patent, designated as T84.66-A3.1-H11, focuses on a hybridoma cell line that produces monoclonal antibodies effective in detecting carcinoembryonic antigens (CEA). These antibodies are particularly useful when applied to tissues and fluids, allowing for the detection of the degree of binding to carcinoembryonic antigens.
Career Highlights
Charles W. Todd is affiliated with the Beckman Research Institute of City of Hope, where he has been involved in groundbreaking research. His work has contributed to advancements in cancer diagnostics, emphasizing the importance of innovative solutions in medical science.
Collaborations
Throughout his career, Todd has collaborated with esteemed colleagues such as Frances G. Crawford and John E. Shively. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in the field.
Conclusion
Charles W. Todd's contributions to the field of biomedical research through his patent and collaborations highlight the vital role of innovation in healthcare. His work continues to impact the detection and understanding of cancer markers, paving the way for future advancements.